Ixabepilone in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer That Has Not Responded to Previous Chemotherapy

Clinical trial NCT00025155 · COMPLETED

Trial details

NCT number: NCT00025155
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Peritoneal Cavity Cancer Recurrent Ovarian Epithelial Cancer

Start date: 2002-07-01
Primary completion: 2010-03-01
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.